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Abstract In recent years the increased use of poly-
cyclic non-steroidal anti-inflammatory drugs has result-
ed in their presence in the environment. This in turnmay
cause potential negative effects on living organisms.
While the biotransformation mechanisms of polycyclic
non-steroidal anti-inflammatory drugs in the human
body and in other mammals have been extensively
studied, degradation of these drugs by microorganisms
has seldom been investigated and is largely unknown.
Biotransformation/biodegradation of polycyclic non-
steroidal anti-inflammatory drugs is caused by fungal
microorganisms, mainly white-rot fungi, and a few
strains of bacteria. However, hitherto only complete
degradation of olsazine was described. The first step of
the transformation ismost often hydroxylation catalyzed
by cytochrom P-450 monooxygenases, or oxygenation
by laccases and three peroxidases: lignin peroxidase,
manganese-dependent peroxidase and versatile per-
oxidase manganese-dependent peroxidase. The aim of
this work is to summarize the knowledge about the
biotransformation and/or biodegradation of polycyclic
non-steroidal anti-inflammatory drugs and to present
their biotransformation pathways.
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1 Introduction
In recent years, the presence of polycyclic non-steroidal
anti-inflammatory drugs (PNSAIDs) in the environment
has been detected. The most popular of these drugs are
naproxen (NPX), diclofenac (DCF), ketoprofen (KEP),
mefenamic acid (MFA), flurbiprofen, indomethacin
(IDM) and olsalazine (ADS), which are polycyclic
nonsteroidal anti-inflammatory agents. These drugs
have been detected in surface water, ground water and
drinking water due to their extensive use in human and
veterinary medicine (Razo-Flores et al. 1997; Ternes
1998; Heberer 2002, Heberer et al. 2002; Bright et al.
2011). Although these pharmaceuticals occur at con-
centrations within the ng l-1 to lg l-1 range and do not
cause acute toxicity, they have a significant potential for
biological activity such as chronic toxicity (Ternes
1998; Schwaiger et al. 2004; Quinn et al. 2008).
Moreover, the removal of many pharmaceuticals in
wastewater treatment plants has been found to be
incomplete. That is why during the past few years much
interest has arisen in the biotransformation of these
contaminants (Thomas and Foster 2005; Gros et al.
2007). This review summarizes what is known about the
biotransformation and/or biodegradation of polycyclic
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NSAIDs, and presents the transformation pathways of
these pharmaceuticals.
Microbial biotransformation of polycyclic non-
steroidal drugs is mainly caused by a few groups of
microorganisms belonging to white-rot fungi (WRF).
They are organisms which have the capability to
degrade a wide range of pollutants, including poly-
cyclic NSAIDs. The elimination of these pharmaceu-
ticals by fungi can be carried out in two phases: surface
binding on the fungal cell (adsorption), followed by a
metabolism-dependent phase where compounds are
transported into the cell and/or they are biotrans-
formed outside the cell by extracellular enzymes.
Extracellular enzymes are secreted basically as essen-
tial for lignin degradation. These nonspecific enzymes
consist of laccases and three peroxidases: lignin
peroxidase (LiP E.C. 1.11.1.14), manganese-depen-
dent peroxidase (MnP, E.C.1.11.1.13) and versatile
peroxidase (VP, E.C. 1.11.1.16). An advantage of the
extracellular ligninolytic enzymes is the catalyzing of
pharmaceuticals, even when the organisms are
metabolically inactive. Moreover, WRF synthesize
intracellular cytochrome P-450 monooxygenase,
which intensifies their potential for degradation.
Biotransformation of pharmaceuticals by WRF using
the cytochrome P-450 system is similar to biotrans-
formation by higher animals (Pointing 2001; Marco-
Urrea et al. 2010a, b, c; Rodriguez-Rodriguez et al.
2013). PNSAID oxidation by this enzyme system
leads to a new intermediate, mainly with the hydroxyl
group. Apart from white-rot fungi the microbial
transformation of polycyclic NSAIDs is also conduct-
ed by Cunninghamella species. These fungi possess
cytochrome P-450 monooxygenase and enzymes
analogous to mammalian enzymes of phase II which
are responsible for drug conjugation with glucuronic
acid or sulfuric acid (Asha and Vidyavathi 2009).
Currently, there is a lack of information about the
bacterial transformation/biodegradation of polycyclic
non-steroidal anti-inflammatory drugs.
2 Naproxen biodegradation/biotransformation
by microorganisms
Naproxen (2S)-2-(6-methoxynaphthalen-2-yl)propa-
noic acid is one of the most widely used medicines
for mild-to-moderate pain relief. Its presence in
different environments is becoming a serious problem
because naproxen and its derivatives have adverse
effects on biota, such as impairing the lipid peroxida-
tion system of bivalves (Zheng et al. 2012). Marco-
Urrea et al. (2010a) carried out almost complete
biotransformation of naproxen by Trametes versicolor
in 24 h. This drug was degraded at a concentration of
10 mg l-1 and 55 lg l-1. A lower concentration was
used because similar amounts of the pharmaceuticals
are found in the environment. However, these authors
observed 23.7 % naproxen adsorption on the surface
of the fungi cells. The drug was catabolized by
ligninolytic enzymes (laccases) as well as cytochrome
P-450 in experimental flasks. Marco-Urrea et al.
(2010a) identified the transformation products of
naproxen: 6-O-desmethylnaproxen (2-(6-hy-
droxynaphthalen-2-yl)propanoic acid) and 1-(6-me-
toxynaphthalen-2-yl) ethanone. The first intermediate
is created as a result of hydroxylation by cytochrome
P-450 monoxygenase. After usage purified laccase
solution in the second metabolite was observed
(Marco-Urrea et al. 2010a) (Fig. 1).
It is known that polycyclic NSAIDs can be removed
from wastewater treatment plants. However, these
compounds are observed in influent and effluent.
Moreover, polycyclic NSAIDs can also be adsorbed in
the sewage sludge. This is why Rodriguez-Rodriguez
et al. (2010a, b) investigated the degradation of
naproxen in sewage sludge in wastewater treatment
plants. Naproxen (to give a final concentration of
*0.096 mg g-1 dry weight) was transformed by T.
versicolor in sewage sludge in three different ex-
periments. The first one consisted in the degradation of
this pharmaceutical in a bottle containing a defined
medium, autoclaved dry sewage sludge and glucose,
which was periodically added (degradation in bioslur-
ry systems). The second, was carried out in a flask
containing dry sewage sludge, and wheat straw pellets
as a lignocellulosic bulking material (degradation in
solid-phase cultures). The third was composed of
sewage sludge of different ages (10, 17, 25, 31, 38, and
45 days). In all experiments dry sewage sludge was
sterilized before mycelium addition. The investigation
of degradation in bioslurry systems has shown that the
drug achieved maximum removal of around 47 %.
Moreover, sorption–desorption equilibrium, which
restores the naproxen concentration in the liquid
phase, was observed. Naproxen transformation
reached 56 % in the other experiments. T. versicolor
in 17-day-old sewage sludge was the most efficient at
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transformation (Rodriguez-Rodriguez et al. 2010a, b):
in younger and older than 17-day-old sludge biotrans-
formation occurred to a lesser degree. Laccase activity
showed a maximum in 17-day-old sewage sludge, but
the activity of laccase was reduced during the
cultivation period (Rodriguez-Rodriguez et al.
2010a, b). Tran et al. (2010) demonstrated that
commercial laccase contributes to more efficient
transformation of naproxen (100 %) than crude
laccase isolated from T. versicolor. Also, Lloret
et al. (2010) have shown that 60 % of naproxen is
removed within 8 h by commercial laccase
(2000 U l-1) from Myceliophthora thermophila with
synthetic and natural mediators (Lloret et al. 2010;
Tran et al. 2010).
Another white-rot fungus able to degrade pharma-
ceuticals is Phanerohaete chrysosporium. It causes the
biotransformation of naproxen at an initial concentra-
tion of 2 mg l-1. After 30 days, this drug was almost
totally removed (up to 97 %). P. chrysosporium has
been grown in air and oxygen reactors with stirring
and the addition of glucose. Although during the
biotransformation of naproxen the activity of man-
ganese-dependent peroxidase was observed, Rodarte-
Morales et al. (2012) suggested the engagement of
cytochrome P-450 in this process. During this study
two unidentified intermediates were isolated (Rodarte-
Morales et al. 2012). Moreover, naproxen was trans-
formed during 4 days in mixtures of drugs (diclofenac,
ibuprofen and carbamazepine) added in a concentra-
tion of 1 mg l-1 (Rodarte-Morales et al. 2011).
The transformation of naproxen by Cunninghamella
species due to its cytochrome P-450 monooxygenase
systems is noteworthy. C. blakesleeana and C. ech-
inulata transformed naproxen into twometabolites after
96 h: 6-O-desmethylnaproxen and desmethylnaproxen-
6-O-sulfate. Whereas C. elegans transformed naproxen
only into 6-O-desmethylnaproxen. The authors sug-
gested a part of the metabolic pathway of naproxen by
Cunninghamella species, based on indicated metabo-
lites and knowledge about mammal metabolism of
naproxen (Fig. 1) (Zhong et al. 2003). He and Rosazza
(2003) detected 6-O-desmethylnaproxen during the
biotransformation of the drug by Aspergillus niger.
Apart from that the authors indicated two previously
unknown naproxenmetabolites (He andRosazza 2003):
7-hydroxynaproxen and 7-hydroxy-6-O-desmethyl-
naproxen (Fig. 1). 6-O-desmethylnaproxen was also
Fig. 1 Microbiological
transformation of naproxen
(He and Rosazza 2003;
Zhong et al. 2003; Marco-
Urrea et al. 2010a; Rodarte-
Morales et al. 2012)
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detected in a cometabolic culture of naproxen
(5 mg l-1) with powdered milk (Quintana et al. 2005)
(Fig. 1).
Borras et al. (2011) carried out soil colonization
with T. versicolor and a biotransformation experiment
of naproxen over 24 h. They added lignocellulosis
substrates such as: maize stalks, wheat straw, rice
husks, pine sawdust, wheat straw pellets and two kinds
of rabbit feedstock. Soil colonization was successful in
sterile and non-sterile soil, while the presence of wheat
straw pellets and two kinds of rabbit feedstock allowed
higher laccase production. The biotransformation
capacity of the fungus was higher when wheat straw
pellets were employed, amounting to *50 %. A
similar result was obtained during the colonization of
sewage sludge in an investigation by Rodriguez-
Rodriguez et al. (2010b). The success of the degrada-
tion process depends on both colonization of the soil
and the degrading ability of the fungus throughout the
treatment period.
3 Microbial degradation/transformation
of diclofenac
Diclofenac (2-{2-[(2,6-dichlorophenyl)amino]pheny-
l}acetic acid) is a commonly used analgesic, anti-
arthritic and anti-rheumatic PNSAID, whose global
consumption amounts to 940 tonnes per year (Coelho
et al. 2009; Al-Rajab et al. 2010). Diclofenac is
characterized by high durability and toxicity in the
environment, despite known examples of biotransfor-
mation for this pharmaceutical (Quintana et al. 2005).
Marco-Urrea et al. (2010a) investigated the biotrans-
formation of diclofenac by Trametes versicolor, and
they observed complete removal (94 %) at a concen-
tration of 10 mg l-1 and 45 lg l-1 (environmental
concentration), while adsorption on the surface of the
fungus cells of diclofenac was valued at 47 %.
Diclofenac was biotransformed to three intermediates
during 24 h. The authors suggest that the cytochrome
P-450 system plays a key role in the transformation of
diclofenac to 40-hydroxydiclofenac and 5-hydroxydi-
clofenac. After the usage of purified laccase, these
authors found 4-(2,6-dichlorophenylamino)-1,3-ben-
zenedimethanol as a metabolite of diclofenac trans-
formation (Fig. 2) (Marco-Urrea et al. 2010c). Also, T.
versicolorwas used to remove diclofenac from sewage
sludge with 64 % efficiency (Rodriguez-Rodriguez
et al. 2011).
Degradation of polycyclic NSAIDs was also
observed by Phanerohaete chrysosporium and P.
sordida YK-624. P. chrysosporium transformed 93 %
of diclofenac (initial concentration 2 mg l-1) after
30 days. Probably, manganese-dependent peroxidase
was engaged in the biotransformation of these
pharmaceuticals. However, the authors did not
exclude the role of cytochrome P-450 in this process.
During this study, two intermediates were isolated
but they were not identified. In the culture of the
second strain—P. sordida YK-624 with diclofenac
40-hydroxydiclofenac (predominant metabolite),
5-hydroxydiclofenac and 40,5–dihydroxydiclofenac
were identified. Metabolites formed via fungal trans-
formation suggested that hydroxylation was cat-
alyzed by monooxygenases cooperating with
cytochrome P-450. However, the authors did not
exclude the role of extracellular ligninolytic enzymes
in diclofenac transformation (90 % during 3 days)
(Hata et al. 2010; Rodarte-Morales et al. 2012). The
same metabolites were indicated in a culture of
bacteria—Actinoplanes sp. Osorio-Lozada et al.
(2008) investigated the transformation of diclofenac
by seven strains of bacteria and 8 strains of fungi.
Only two bacterial strains and five fungal strains were
able to biotransform of drug. Actinoplanes sp.
hydroxylated diclofenac (50 lM) more efficiently
than other strains (100 % of diclofenac during 5 h),
whereas Cunninghamella elegans, Cunninghamella
echinulata and Beauveria bassiana transformed
100 % of this drug within 120 h (Osorio-Lozada
et al. 2008).
40-Hydroxydiclofenac also appeared in a large
amount from biotransformation by recombinant
Escherichia coli and Epiccocum nigrum IMI354292.
Pestalotiopsis sp. IMI353656 and E. nigrum
IMI356573 produced small amounts of 30-hydroxydi-
clofenac and 5-hydroxydiclofenac, along with 40-
hydroxydiclofenac, while Pestalotiopsis sp. IMI35348
transformed diclofenac to 5-hydroxydiclofenac and
40-hydroxydiclofenac (Webster et al. 1998; Vail et al.
2005).
Groning et al. (2007) investigated diclofenac degrada-
tion in river sediment. The authors assayed intermediates
of diclofenac: 40-hydroxydiclofenac, 5-hydroxydiclofenac
and the major metabolite of 5-hydroxydiclofenac—p-
benzoquinone imine. Enzymes were not indicated, but it
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was suggested that p-benzoquinone iminewas formed out
of 5-hydroxydiclofenac by dehydratation (Fig. 2) (Gron-
ing et al. 2007).
Removal of diclofenac by microorganisms from a
mixture of selected pharmaceuticals was also reported.
99 % of this drug (concentration of the drug mixture:
*1 mg l-1) was transformed within 4 days by
Bjerkandera sp. R1, while P. chrysosporum and
Bjerkandera adusta transformed 12 and 9 % of
diclofenac within 7 days, respectively. However, the
authors did not observe and did not identify metabo-
lites (Rodarte-Morales et al. 2011).
Diclofenac transformation was also observed by
pure enzymes—laccase—from cell free extract of T.
versicolor, and commercial laccase from T. versicolor.
It was observed that the degradation of diclofenac
increased with the increase of laccase activity, or
through the addition of redox mediators such as
syringaldehyde. Moreover, it was suggested that the
presence of nitrogen and the negative charge in the
diclofenac ring may facilitate the degradation of these
compounds by laccase (Lloret et al. 2010; Tran et al.
2010).
4 Biodegradation/biotransformation
of ketoprofen
Ketoprofen 2-(3-benzoylphenyl)propanoic acid is a
type of PNSAID which has been detected in soil,
surface water and in influents and effluents of waste-
water treatment plants in concentrations ranging from
ng l-1 up to lg l-1 (Xu et al. 2009; Marco-Urrea et al.
2010b; Almeida et al. 2013). Adsorption and trans-
formation of ketoprofen in soil are among the
processes dependent on biotic and abiotic factors in
soil. Xu et al. (2009) showed that ketoprofen was not
strongly adsorbed in soil. These authors showed that
degradation of the drug depends on physical and
chemical properties of soil, total soil microbial
activity, and bioavailability, as well as inherence of
light intensity (Matamoros et al. 2009; Xu et al. 2009).
It has been shown that ketoprofen may be trans-
formed by microorganisms, mainly by fungi. Marco-
Urrea et al. (2010b) showed that Trametes versicolor
biotransformed ketoprofen at a concentration of
40 lg l-1 (the concentration of ketoprofen in the
environment) and 10 mg l-1. They observed 15 %
Fig. 2 Transformation of
diclofenac by
microorganisms (Groning
et al. 2007; Marco-Urrea
et al. 2010c)
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adsorption of ketoprofen on the surface of fungal cells.
Probably, ketoprofen degradation occurred with the
usage of cytochrome P-450. Extracellular activities of
laccase were detected, but transformation of the drug
was not observed in a study with purified laccase.
During the transformation of ketoprofen by whole
fungal cells, crude laccase and commercial laccase,
Tran et al. (2010) observed 100, 25, and 50 %
transformation, respectively. This suggests that the
biotransformation of the drug by whole fungal cultures
may probably also be effected by intracellular oxidiz-
ing activities (Tran et al. 2010).
Marco-Urrea et al. (2010b) identified three metabo-
lites of ketoprofen transformation by Trametes versi-
color: 2-[(3-hydroxy(phenyl)methyl)phenyl]-propanoic
acid, the major degradation metabolite formed by
reduction of the ketone group, and 2-(3-benzoyl-4-
hydroxyphenyl)propanoic acid and/or 2-(3-(4-hy-
droxybenzoyl)phenyl)propanoic acid, which were
formed by hydroxylation (Fig. 3).
Quintana et al. (2005) proposed the degradation
pathway of ketoprofen by activated sludge. Based on
these metabolites, the authors proposed that ketoprofen
is degraded along the pathway known for biphenyls,
biphenyl ethers and related compounds. The first step of
ketoprofen degradation was the reduction of the keto
group. This led to electron density of the ring, which
was more reactive towards electrophilic dioxygenation.
As a consequence, the respective catechol derivatives
were formed, which undergo extradiol cleavage to
hydroxymuconic semialdehyde. This intermediate was
hydrolysed to hydroxyl-pentadienoic acid and 3-(hy-
droxyl-carboxymethyl) hydratopic acid. These com-
pounds oxidized to 3-(keto-carboxymethyl) hydratopic
acid (Fig. 3) (Quintana et al. 2005).
5 Mefenamic acid, indomethacin and flurbiprofen
biodegradation/biotransformation
by microorganisms
Mefenamic acid (2-[(2,3-dimethylphenyl)amino]ben-
zoic acid), indomethacin ((2-{1-[(4-chlorophenyl)car-
bonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic
acid)) and flurbiprofen ((2-(3-fluoro-4-biphenyl)pro-
panoic acid)) are used less often than the earlier
described PNSAIDs. However, they and their metabo-
lites are detected in the aquatic environment (Chowd-
hury et al. 2003; Amadio et al. 2010; Hata et al. 2010).
Mefenamic acid exhibits a high ability of binding to
solids (Jones et al. 2006). Nevertheless, it was up to
72 % removed by sewage sludge with T. versicolor,
and a strong decrease in toxicity was observed. During
this study laccase activity was indicated, but its level
was variable (Rodriguez-Rodriguez et al. 2011).
Hata et al. (2010) examined the biotransformation
of mefenamic acid by Phanerochaete sordida YK-
624. During this study, they observed about 60 and
90 % depletion of the introduced dose after 3 and
6 days of treatment, respectively. The appearance of
four intermediates: 30-hydroxymefenamic acid, 30-
carboxymefenamic acid, 30-hydroxymethyl-60-hy-
droxymefenamic acid and 30-hydroxymethyl-5-hy-
droxymefenamic acid (Fig. 4) suggests that the
cytochrome P-450 system is responsible mainly for
the elimination of mefenamic acid. However, the roles
of laccase, manganese-dependent peroxidase and
lignin peroxidase in the transformation of ketoprofen
could not be excluded (Fig. 4) (Hata et al. 2010).
It is known that flurbiprofen shows a strong
antifungal activity (Chowdhury et al. 2003). In the
environment, fungi which able to transform this drug
are nevertheless found. Amadio et al. (2010) revealed
flurbiprofen transformation to 40-hydroxyflurbiprofen
and 30-hydroxy-40-methoxyflurbiprofen, as well as to
30,40-dihydroxyflurbiprofen by Cunninghamella spe-
cies: C. elegans DSM 1908, C. echinulata DSM 1905
and C. blakesleeana DSM 1906. C. elegans strains
DSM 8217 and DSM 63299 were able to transform
flurbiprofen only to 40-hydroxyflurbiprofen and 30-
hydroxy-40-methoxyflurbiprofen. The appearance of
these metabolites allows us to speculate on the
hydroxylating role of the cytochrome P-450 systems
in the biotransformation of flurbiprofen. Moreover, C.
elegans DSM 1908 and C. blakesleeana DSM 1906
also produced a sulfated drug—an analog of the II
phase metabolite of the mammalian detoxification
system (Fig. 5) (Amadio et al. 2010).
Also bacteria take part in the biological transforma-
tion of flurbiprofen. Bright et al. (2011) conducted its
transformation in cultures of Streptomyces sp. The
intermediates 40-hydroxyflurbiprofen, 30,40-dihydrox-
yflurbiprofen and 30-methoxy-40-hydroxyflurbiprofen
were detected in the culture medium of S. griseus
ATCC 13273 and S. griseus DSM 40236. S. griseus
DSM 40226 and S. rimosus DSM 40260 hydroxylated
flurbiprofen to 40-hydroxyflurbiprofen, while S. subru-
tilis DSM 40445 transformed the examined compound
234 Rev Environ Sci Biotechnol (2015) 14:229–239
123
to 40-hydroxyflurbiprofen and 30-methoxy-40-hydrox-
yflurbiprofen. The enzymes engaged in flurbiprofen
transformation are probably analogs of mammalian
cytochromes P-450. Moreover, S. lavenduligriseus
DSM 40487, Bacillus subtilis IM7, B. megaterium
NCIMB8291 andB.megateriumATCC14581 produced
flurbiprofenamide and 7-hydroxyflurbiprofenamide as
metabolites of flurbiprofen (Fig. 5) (Bright et al. 2011).
Zhang et al. (2006) examined the biotransformation
of indomethacin by Cunninghamella blakesleeana AS
3.910. The drug was partially metabolized (87.41 %)
to three metabolites: O-desmethylindomethacin, N-
deschlorobenzoylindomethacin and O-desmethyl-N-
deschlorobenzoylindomethacin. Transformation of
the drug was also carried out by C. elegans AS
3.156 (38.76 %), C. elegansAS 3.2028 (69.29 %), C.
blakesleeana AS 3.153 (51.90 %) and C. echinulata
AS 3.2004 (39.52 %), but metabolites of in-
domethacin were not identified (Zhang et al. 2006)
(Fig. 6).
Tran et al. (2010) observed the complete biotrans-
formation of indomethacin by a whole fungal culture
of T. versicolor. The experiment with crude laccase
and commercial laccase showed that this enzyme is
probably engaged in the biotransformation process.
The nitrogen atom in the structure of indomethacin
accelerates the reaction with laccase (Tran et al.
2010).
Fig. 3 Biotransformation
of ketoprofen (Quintana
et al. 2005; Marco-Urrea
et al. 2010b)
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Fig. 4 Biotransformation
of mefenamic acid by
Phanerochaete sordida YK-
624 (Hata et al. 2010)
Fig. 5 Microbiological
transformation of
flurbiprofen (Amadio et al.
2010; Bright et al. 2011)
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6 Degradation of olsalazine as an example
of PNSAIDs from the azo dye group
Olsalazine (5-[(E)-2-(3-carboxy-4-hydroxyphenyl)di-
azen-1-yl]-2-hydroxybenzoic acid) is known as
azodisalicylate and belongs to the azo dye group.
This drug is resistant to aerobic transformations by
bacteria because the azo group has a strong electron-
withdrawing character and stabilizes this aromatic
compound against conversion by oxygenases (Keck
et al. 1997). Razo-Flores et al. (1997) described the
89 % transformation of olsalazine by a methanogenic
consortium immobilized in sludge granules during
7 months under anaerobic conditions. Glucose and a
mixture of acetate, propionate, and butyrate were used
as the co-substrate to provide the electrons for the
olsalazine reductive cleavage. During experiments,
the authors assayed the metabolite, 5-aminosalicylic
acid, which was created throughout azo bond reduc-
tion. In the subsequent biotransformation period,
5-aminosalicylic acid was extensively mineralized
by the methanogenic consortium to methane and
ammonium, which were observed in the bioreactors.
When 5-aminosalicylic acid was incubated with a
specific methanogenic inhibitor, acetate was identified
as the major intermediate of olsalazine (Fig. 7) (Razo-
Flores et al. 1997).
7 Conclusion
The polycyclic non-steroidal anti-inflammatory drugs
present in wastewater can be biotransformed by
microorganisms, but only olsazine is completely
degraded. White-rot fungi are a group of microorgan-
ism with a large ability to transformation polycyclic
NSAIDs. T. versicolor could be used as an agent for
the degradation of mainly pharmaceuticals, but it still
requires further studies. The presented pathways of
biotransformation for selected drugs are not complete.
In many case enzymes were not indicated, or it is only
speculation about their activity. There are known
physical–chemical treatment methods which usually
achieve high removal efficiencies. However, they
Fig. 6 Biotransformation
of indomethacin by fungi
(Zhang et al. 2006)
Fig. 7 Biotransformation
of olsalazine by
methanogenic consortium
(Razo-Flores et al. 1997)
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sometimes lead to the accumulation of intermediates
more toxic than the parent compounds. Biological
degradation could be more economically and envi-
ronment friendly, but it requires knowledge of the
polycyclic NSAIDs degradation pathways, and not
just the biotransformation pathways.
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